This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ye Wu - Innovator in Cancer Treatment
Introduction
Ye Wu is an accomplished inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of cancer treatment through her innovative research. Her work focuses on developing new therapeutic agents that can inhibit specific kinases involved in cancer progression.
Latest Patent Applications
Ye Wu's notable patent application is titled "SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER." This application discloses certain substituted pyrazine-2-carboxamides of Formula (I), along with their pharmaceutically acceptable salts. The compounds are designed to act as inhibitors of hematopoietic progenitor kinase 1 (HPK1), making them particularly useful in the treatment or prophylaxis of cancer.
Conclusion
Ye Wu's innovative approach to cancer treatment through her patent application highlights her commitment to advancing medical science. Her work has the potential to contribute significantly to therapeutic options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile